Feihu Xie
Peking Union Medical College Hospital
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Bioprinting of patient-derived in vitro intrahepatic cholangiocarcinoma tumor model: establishment, evaluation and anti-cancer drug testing.
Journal: Biofabrication
Published: June 30, 2020
Three-dimensional bio-printing of primary human hepatocellular carcinoma for personalized medicine.
Journal: Biomaterials
Published: May 13, 2020
Albumin binding function is a novel biomarker for early liver damage and disease progression in non-alcoholic fatty liver disease.
Journal: Endocrine
Published: February 20, 2020
Application of a 3D Bioprinted Hepatocellular Carcinoma Cell Model in Antitumor Drug Research.
Journal: Frontiers in oncology
Published: January 14, 2020
Alcohol consumption as a cause of cancer: urging for more mechanism study.
Journal: Hepatobiliary surgery and nutrition
Published: June 28, 2019
The Clinicopathological and Prognostic Value of PD-L1 Expression in Cholangiocarcinoma: A Meta-Analysis.
Journal: Frontiers in oncology
Published: May 28, 2019
Extracellular vesicles in hepatocellular cancer and cholangiocarcinoma.
Journal: Annals of translational medicine
Published: April 26, 2019
The first-line treatment for unresectable hepatocellular carcinoma patients: lenvatinib versus sorafenib, or beyond?
Journal: Hepatobiliary surgery and nutrition
Published: July 27, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026